Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gary Nicholls

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Urocortin-1 infusion in normal humansMark E Davis, Chris J Pemberton, Timothy G Yandle, et al.
American Journal of Hypertension|November 25, 2011
A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndromeJoanna M Young, Christopher M Florkowski, Sarah L Molyneux, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2002
Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failureMiriam T Rademaker, Chris J Charles, Garth J S Cooper, et al.
Clinical Science (London, England : 1979)|June 7, 2002
Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failureMiriam T Rademaker, Chris J Charles, Garth J S Cooper, et al.
Circulation|July 28, 2004
Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trialMichele M Ciulla, Roberta Paliotti, Arturo Esposito, et al.
Journal of the American College of Cardiology|February 2, 2010
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trialJohn G Lainchbury, Richard W Troughton, Kim M Strangman, et al.
The New Zealand Medical Journal|October 4, 2011
Prediction of cardiac rhythm 1 year following cardioversion for atrial fibrillationAmjad K Hamid, A Mark Richards, Ian G Crozier, et al.
Circulation|May 29, 2003
B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarctionA Mark Richards, M Gary Nicholls, Eric A Espiner, et al.
The New Zealand Medical Journal|August 20, 2010
Patients "falling through the cracks". The Canterbury Charity Hospital: initial progress reportPhilip F Bagshaw, Randall A Allardyce, Susan N Bagshaw, et al.
Clinical Chemistry|January 14, 2014
B-type natriuretic peptide forms within the heart, coronary sinus, and peripheral circulation in humans: evidence for degradation before secretionPatalee G Mahagamasekera, Peter N Ruygrok, Suetonia C Palmer, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Urocortin-1 infusion in normal humansMark E Davis, Chris J Pemberton, Timothy G Yandle, et al.
American Journal of Hypertension|November 25, 2011
A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndromeJoanna M Young, Christopher M Florkowski, Sarah L Molyneux, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2002
Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failureMiriam T Rademaker, Chris J Charles, Garth J S Cooper, et al.
Clinical Science (London, England : 1979)|June 7, 2002
Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failureMiriam T Rademaker, Chris J Charles, Garth J S Cooper, et al.
Circulation|July 28, 2004
Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trialMichele M Ciulla, Roberta Paliotti, Arturo Esposito, et al.
Journal of the American College of Cardiology|February 2, 2010
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trialJohn G Lainchbury, Richard W Troughton, Kim M Strangman, et al.
The New Zealand Medical Journal|October 4, 2011
Prediction of cardiac rhythm 1 year following cardioversion for atrial fibrillationAmjad K Hamid, A Mark Richards, Ian G Crozier, et al.
Circulation|May 29, 2003
B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarctionA Mark Richards, M Gary Nicholls, Eric A Espiner, et al.
The New Zealand Medical Journal|August 20, 2010
Patients "falling through the cracks". The Canterbury Charity Hospital: initial progress reportPhilip F Bagshaw, Randall A Allardyce, Susan N Bagshaw, et al.
Clinical Chemistry|January 14, 2014
B-type natriuretic peptide forms within the heart, coronary sinus, and peripheral circulation in humans: evidence for degradation before secretionPatalee G Mahagamasekera, Peter N Ruygrok, Suetonia C Palmer, et al.
Pageof 8